Stock Screener
Stock Research
Market Indexes
Precious Metals
Energy
Commodities
Interest Rates
Economy
Global Metrics

Avadel Pharmaceuticals - 29 Year Stock Price History | AVDL

Historical daily share price chart and data for Avadel Pharmaceuticals since 1996 adjusted for splits and dividends. The latest closing stock price for Avadel Pharmaceuticals as of June 26, 2025 is 9.29.
  • The all-time high Avadel Pharmaceuticals stock closing price was 42.85 on September 19, 2003.
  • The Avadel Pharmaceuticals 52-week high stock price is 17.30, which is 86.2% above the current share price.
  • The Avadel Pharmaceuticals 52-week low stock price is 6.38, which is 31.3% below the current share price.
  • The average Avadel Pharmaceuticals stock price for the last 52 weeks is 11.23.
For more information on how our historical price data is adjusted see the Stock Price Adjustment Guide.
  
Avadel Pharmaceuticals Historical Annual Stock Price Data
Year Average Stock Price Year Open Year High Year Low Year Close Annual % Change
2025 8.5758 11.0000 11.0600 6.5900 9.2900 -11.61%
2024 14.6326 14.2800 18.8200 9.9400 10.5100 -25.57%
2023 11.5979 7.0000 16.4800 6.4100 14.1200 97.21%
2022 5.8754 8.2900 10.0000 1.0700 7.1600 -11.39%
2021 8.2633 6.6600 11.1800 6.4900 8.0800 20.96%
2020 7.5003 7.4100 11.7500 4.0600 6.6800 -11.52%
2019 2.9547 2.7800 7.7000 1.0900 7.5500 192.64%
2018 6.1353 8.8000 11.7000 1.7400 2.5800 -68.54%
2017 9.7399 10.9500 11.5700 8.0300 8.2000 -21.08%
2016 11.1777 12.9200 14.8900 7.8500 10.3900 -14.91%
2015 17.8260 17.0900 25.6900 11.5000 12.2100 -28.72%
2014 12.8868 8.1500 18.8900 8.1500 17.1300 112.80%
2013 5.6143 3.2500 8.2100 3.2500 8.0500 165.68%
2012 4.7775 5.1900 7.6700 2.9900 3.0300 -41.84%
2011 5.3715 6.9700 6.9700 3.8500 5.2100 -23.83%
2010 7.5251 7.5300 9.6000 6.0200 6.8400 -7.57%
2009 6.9922 4.2220 9.6700 3.9900 7.4000 88.78%
2008 8.4074 10.6500 10.8000 3.6800 3.9200 -60.72%
2007 20.4977 31.7200 36.9700 8.1700 9.9800 -66.68%
2006 21.4849 18.5000 34.8800 16.7000 29.9500 58.63%
2005 17.4514 19.6500 21.3700 12.2500 18.8800 -3.13%
2004 22.1121 27.1600 31.7300 14.6700 19.4900 -27.25%
2003 17.3224 4.0500 42.8540 3.7400 26.7900 515.86%
2002 2.2781 2.7090 4.8500 1.2000 4.3500 59.93%
2001 3.0912 6.5625 7.0625 0.9400 2.7200 -62.48%
2000 5.5673 2.1875 11.3750 2.0000 7.2500 241.18%
1999 2.9355 4.0000 4.6250 1.0000 2.1250 -51.43%
1998 4.1381 2.1250 5.5625 2.1250 4.3750 141.38%
1997 4.7713 7.3750 7.7500 1.7500 1.8125 -75.83%
Sector Industry Market Cap Revenue
Medical Medical - Drug Manufacturing $0.913B $0.169B
Avadel Pharmaceuticals plc is a specialty pharmaceutical company. Its product pipeline consists of hospital and paediatrics. Hospital segment provides Bloxiverz(R), Vazculep(R) and Akovaz(TM). Paediatrics segment provides Karbinal (TM) ER, AcipHex(R) Sprinkle and Flexichamber(TM). The company operates primarily in Ireland, USA and France. Avadel Pharmaceuticals plc, formerly known as Flamel Technologies SA, is headquartered in Lyon, France.
Stock Name Country Market Cap PE Ratio
Chugai Pharmaceutical (CHGCY) Japan $85.731B 32.16
Zoetis (ZTS) United States $70.000B 26.12
Takeda Pharmaceutical (TAK) Japan $47.633B 9.47
Daiichi Sankyo, - (DSNKY) Japan $43.873B 22.49
BeOne Medicines - (ONC) Cayman Islands $29.277B 0.00
Sandoz Group AG (SDZNY) Switzerland $23.324B 0.00
Merck (MKKGY) Germany $16.717B 12.25
Summit Therapeutics (SMMT) United States $15.797B 0.00
Shionogi (SGIOY) Japan $14.785B 14.81
United Therapeutics (UTHR) United States $12.899B 11.41
Neurocrine Biosciences (NBIX) United States $12.646B 43.31
Orion OYJ (ORINY) Finland $10.469B 28.31
IPSEN (IPSEY) France $9.739B 0.00
Corcept Therapeutics (CORT) United States $7.846B 63.78
Stevanato Group S.p.A (STVN) Italy $7.647B 46.76
Ionis Pharmaceuticals (IONS) United States $6.366B 0.00
Madrigal Pharmaceuticals (MDGL) United States $6.165B 0.00
Hikma Pharmaceuticals Plc (HKMPF) United Kingdom $6.153B 0.00
Grifols, S.A (GRFS) Spain $5.851B 0.00
Ono Pharmaceutical (OPHLF) Japan $4.382B 13.33
Soleno Therapeutics (SLNO) United States $4.323B 0.00
Hypermarcas (HYPMY) Brazil $2.977B 19.58
Crinetics Pharmaceuticals (CRNX) United States $2.847B 0.00
Catalyst Pharmaceuticals (CPRX) United States $2.627B 9.21
AMNEAL PHARMACEUTICALS, INC (AMRX) United States $2.523B 13.64
NewAmsterdam Pharma (NAMS) Netherlands $2.058B 0.00
BioCryst Pharmaceuticals (BCRX) United States $2.038B 0.00
Indivior (INDV) United States $1.893B 8.03
Centessa Pharmaceuticals (CNTA) United Kingdom $1.794B 0.00
ARS Pharmaceuticals (SPRY) United States $1.695B 0.00
Endo (NDOI) United States $1.603B 0.00
Evotec AG (EVO) Germany $1.477B 0.00
Ocular Therapeutix (OCUL) United States $1.464B 0.00
Guardian Pharmacy Services (GRDN) United States $1.285B 0.00
Dyne Therapeutics (DYN) United States $1.184B 0.00
Harrow (HROW) United States $1.157B 0.00
Aurinia Pharmaceuticals Inc (AUPH) Canada $1.085B 21.70
Enliven Therapeutics (ELVN) United States $1.055B 0.00
Verve Therapeutics (VERV) United States $0.999B 0.00
Akebia Therapeutics (AKBA) United States $0.967B 0.00
Collegium Pharmaceutical (COLL) United States $0.957B 5.16
Ardelyx (ARDX) United States $0.869B 0.00
Elite Pharmaceuticals (ELTP) United States $0.816B 0.00
Xeris Biopharma Holdings (XERS) United States $0.737B 0.00
Cronos Group (CRON) Canada $0.729B 0.00
Altimmune (ALT) United States $0.625B 0.00
Liminatus Pharma (LIMN) United States $0.624B 0.00
Xencor (XNCR) United States $0.609B 0.00
KalVista Pharmaceuticals (KALV) United States $0.581B 0.00
USANA Health Sciences (USNA) United States $0.575B 12.49
Regulus Therapeutics (RGLS) United States $0.565B 0.00
Relay Therapeutics (RLAY) United States $0.559B 0.00
Amylyx Pharmaceuticals (AMLX) United States $0.558B 0.00
Bioventus (BVS) United States $0.550B 13.94
Theravance Biopharma (TBPH) United States $0.529B 0.00
Zevra Therapeutics (ZVRA) United States $0.510B 0.00
AleAnna (ANNA) United States $0.483B 0.00
Siga Technologies (SIGA) United States $0.460B 9.61
Organogenesis (ORGO) United States $0.449B 0.00
Tourmaline Bio (TRML) United States $0.436B 0.00
Oruka Therapeutics (ORKA) United States $0.435B 0.00
Savara (SVRA) United States $0.379B 0.00
Nektar Therapeutics (NKTR) United States $0.361B 0.00
Rigel Pharmaceuticals (RIGL) United States $0.333B 9.00
Heron Therapeutics (HRTX) United States $0.328B 0.00
Aquestive Therapeutics (AQST) United States $0.323B 0.00
Nature's Sunshine Products (NATR) United States $0.274B 25.15
Tonix Pharmaceuticals Holding (TNXP) United States $0.250B 0.00
ProKidney (PROK) United States $0.226B 0.00
Nanobiotix S.A (NBTX) France $0.214B 0.00
MediWound (MDWD) Israel $0.211B 0.00
Aldeyra Therapeutics (ALDX) United States $0.210B 0.00
Larimar Therapeutics (LRMR) United States $0.208B 0.00
OmniAb (OABI) United States $0.203B 0.00
Esperion Therapeutics (ESPR) United States $0.200B 0.00
4D Molecular Therapeutics (FDMT) United States $0.189B 0.00
Profound Medical (PROF) Canada $0.180B 0.00
Aclaris Therapeutics (ACRS) United States $0.177B 0.00
Innate Pharma SA (IPHYF) France $0.163B 0.00
Journey Medical (DERM) United States $0.162B 0.00
Galectin Therapeutics (GALT) United States $0.159B 0.00
Lexeo Therapeutics (LXEO) United States $0.139B 0.00
Lyell Immunopharma (LYEL) United States $0.138B 0.00
Achieve Life Sciences (ACHV) Canada $0.132B 0.00
Avita Medical (RCEL) United States $0.126B 0.00
Inhibikase Therapeutics (IKT) United States $0.124B 0.00
VAXART, INC (VXRT) United States $0.123B 0.00
Ironwood Pharmaceuticals (IRWD) United States $0.121B 0.00
Cardiol Therapeutics (CRDL) Canada $0.120B 0.00
Korro Bio (KRRO) United States $0.112B 0.00
Protara Therapeutics (TARA) United States $0.112B 0.00
Corbus Pharmaceuticals Holdings (CRBP) United States $0.106B 0.00
Champions Oncology (CSBR) United States $0.105B 17.20
Arch Biopartners (ACHFF) Canada $0.091B 0.00
Cassava Sciences (SAVA) United States $0.089B 0.00
Nutriband (NTRB) United States $0.086B 0.00
Fractyl Health (GUTS) United States $0.085B 0.00
Dominari Holdings (DOMH) United States $0.081B 0.00
Pyxis Oncology (PYXS) United States $0.079B 0.00
Unicycive Therapeutics (UNCY) United States $0.079B 0.00
ESSA Pharma (EPIX) Canada $0.077B 0.00
Vivani Medical (VANI) United States $0.077B 0.00
Surrozen (SRZN) United States $0.074B 0.00
Wellgistics Health (WGRX) United States $0.066B 0.00
Inotiv (NOTV) United States $0.062B 0.00
Assertio Holdings (ASRT) United States $0.060B 0.00
Context Therapeutics (CNTX) United States $0.059B 0.00
Allergy Therapeutics (AGYTF) United Kingdom $0.059B 0.00
Gain Therapeutics (GANX) United States $0.058B 0.00
Metagenomi (MGX) United States $0.058B 0.00
Rafael Holdings (RFL) United States $0.058B 0.00
PMV Pharmaceuticals (PMVP) United States $0.057B 0.00
NRx Pharmaceuticals (NRXP) United States $0.057B 0.00
Verrica Pharmaceuticals (VRCA) United States $0.055B 0.00
Telomir Pharmaceuticals (TELO) United States $0.053B 0.00
Avalo Therapeutics (AVTX) United States $0.052B 0.00
Century Therapeutics (IPSC) United States $0.049B 0.00
Prelude Therapeutics (PRLD) United States $0.048B 0.00
Mural Oncology (MURA) Ireland $0.042B 0.00
Acrivon Therapeutics (ACRV) United States $0.042B 0.00
Iterum Therapeutics (ITRM) Ireland $0.041B 0.00
Klotho Neurosciences (KLTO) United States $0.041B 0.00
Karyopharm Therapeutics (KPTI) United States $0.039B 0.00
ElectroCore (ECOR) United States $0.039B 0.00
Cumberland Pharmaceuticals (CPIX) United States $0.038B 28.33
PolyPid (PYPD) Israel $0.038B 0.00
Jupiter Neurosciences (JUNS) United States $0.037B 0.00
Reviva Pharmaceuticals Holdings (RVPH) United States $0.036B 0.00
Enlivex Therapeutics (ENLV) Israel $0.030B 0.00
SCYNEXIS (SCYX) United States $0.029B 0.00
China SXT Pharmaceuticals (SXTC) China $0.027B 0.00
Tempest Therapeutics (TPST) United States $0.026B 0.00
FibroGen (FGEN) United States $0.023B 0.00
Natural Alternatives (NAII) United States $0.021B 0.00
VYNE Therapeutics (VYNE) United States $0.021B 0.00
DURECT (DRRX) United States $0.020B 0.00
BioVie (BIVI) United States $0.019B 0.00
BioLineRx (BLRX) Israel $0.019B 0.00
Mannatech (MTEX) United States $0.019B 0.00
Vivos Therapeutics (VVOS) United States $0.018B 0.00
Relmada Therapeutics (RLMD) United States $0.018B 0.00
Lipocine (LPCN) United States $0.017B 0.00
Carisma Therapeutics (CARM) United States $0.017B 0.00
MARKER THERAPEUTICS, INC (MRKR) United States $0.017B 0.00
Lyra Therapeutics (LYRA) United States $0.016B 0.00
CASI Pharmaceuticals (CASI) China $0.016B 0.00
ProPhase Labs (PRPH) United States $0.015B 0.00
Ernexa Therapeutics (ERNA) United States $0.014B 0.00
TherapeuticsMD (TXMD) United States $0.014B 0.00
Scienture Holdings (SCNX) United States $0.013B 0.00
Citius Pharmaceuticals (CTXR) United States $0.013B 0.00
Minerva Neurosciences (NERV) United States $0.013B 2.22
Cosmos Health (COSM) United States $0.013B 0.00
Crescent Biopharma (CBIO) United States $0.012B 0.00
Ainos (AIMD) United States $0.011B 0.00
Phio Pharmaceuticals (PHIO) United States $0.010B 0.00
Addex Therapeutics (ADXN) Switzerland $0.010B 0.00
Mangoceuticals (MGRX) United States $0.009B 0.00
Kiora Pharmaceuticals (KPRX) United States $0.009B 0.00
Talphera (TLPH) United States $0.009B 0.00
NLS Pharmaceutics (NLSP) Switzerland $0.009B 0.00
Biomerica (BMRA) United States $0.008B 0.00
Traws Pharma (TRAW) United States $0.008B 0.00
Alaunos Therapeutics (TCRT) United States $0.007B 0.00
Nuvilex (PMCB) United States $0.007B 0.00
XTL Biopharmaceuticals (XTLB) Israel $0.007B 0.00
TransCode Therapeutics (RNAZ) United States $0.006B 0.00
Incannex Healthcare (IXHL) Australia $0.006B 0.00
Xenetic Biosciences (XBIO) United States $0.006B 0.00
Indaptus Therapeutics (INDP) United States $0.006B 0.00
Quoin Pharmaceuticals (QNRX) United States $0.006B 0.00
Aptorum Group (APM) United Kingdom $0.005B 0.00
Plus Therapeutics (PSTV) United States $0.005B 0.00
Sonoma Pharmaceuticals (SNOA) United States $0.005B 0.00
InMed Pharmaceuticals (INM) Canada $0.005B 0.00
CERo Therapeutics Holdings (CERO) United States $0.004B 0.00
SHINECO (SISI) China $0.004B 0.00
Redhill Biopharma (RDHL) Israel $0.004B 0.00
Clearmind Medicine (CMND) Canada $0.004B 0.00
60 Degrees Pharmaceuticals (SXTP) United States $0.004B 0.00
SciSparc (SPRC) Israel $0.004B 0.00
Aditxt (ADTX) United States $0.003B 0.00
XORTX Therapeutics (XRTX) Canada $0.003B 0.00
Heatwurx (PCSA) United States $0.003B 0.00
Galmed Pharmaceuticals (GLMD) Israel $0.003B 0.00
Jaguar Animal Health (JAGX) United States $0.003B 0.00
PainReform (PRFX) Israel $0.003B 0.00
Qualigen Therapeutics (QLGN) United States $0.003B 0.00
Salarius Pharmaceuticals (SLRX) United States $0.002B 0.00
Conduit Pharmaceuticals (CDT) United States $0.002B 0.00
TNF Pharmaceuticals (TNFA) United States $0.002B 0.00
Shuttle Pharmaceuticals Holdings (SHPH) United States $0.002B 0.00
Universe Pharmaceuticals INC (UPC) China $0.000B 0.00
4D Pharma (LBPS) United Kingdom $0.000B 0.00
MEI Pharma (MEIP) United States $0.000B 0.00
Patheon (PTHN) Netherlands $0.000B 0.00
RVL Pharmaceuticals (RVLP) United States $0.000B 0.00
Silence Therapeutics (SLN) United Kingdom $0.000B 0.00